ANGOLA POPULATION: 30 MILLION

WHO GLOBAL TB REPORT 2018

2017

107 000 FELL ILL WITH TB 28 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
120
67 000 40 000 11 000

Rate per 100 000 population per year

males females children 100

80

60
52 599
54 401 people not 40

TB cases notified or not

notified diagnosed
20

including 7 800 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 600
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

500
TB treatment coverage Treatment success rate Incidence
TUBERCULOSIS

90 %
400

51 %
27 %
300

End TB 200
operational Notified (new and relapse)
targets 100

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

3 900
people fell ill with
drug-resistant TB
534 notified
18 000
people living with
2017 3 613 notified

534 started on treatment HIV fell ill with TB 1 401 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 46 million
50

13 %
HIV-positive people
Not reported
Children (aged <5 years)
40 Unfunded
(US$ millions)

30
(newly enrolled household contacts of Funded
bacteriologically-confirmed TB 20 internationally
in care) on TB
preventive treatment cases on TB preventive treatment 10 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking Data not available
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
8.5% (M) 8.6% (M) 5 risk factors
33% 1.9% — HIV
7.8% (F) 1.4% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 10 20 30
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 BANGLADESH POPULATION: 165 MILLION
WHO GLOBAL TB REPORT 2018

2017

364 000 FELL ILL WITH TB 60 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
120
230 000 134 000 35 000

Rate per 100 000 population per year

males females children 100

80

60
121 361
242 639 people not 40

TB cases notified or not

notified diagnosed
20

including 170 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 300
TB INCIDENCE 2000-2017
2025 Incidence

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

90 %
200

67% End TB
operational
94% 100

Notified (new and relapse)

targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

8 400
people fell ill with
drug-resistant TB
944 notified

people living with

550 2017 89 notified

920 notified and started on treatment HIV fell ill with TB 84 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 66 million

Not reported
HIV-positive people
21% 80

60 Unfunded
Children (aged <5 years)
(newly enrolled
(US$ millions)

household contacts of 40 Funded

in care) on TB bacteriologically-confirmed TB internationally
preventive treatment cases on TB preventive treatment 20 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
44.7% (M) 10% (M) 1.3% (M) 5 risk factors
72% 0.1% HIV
1% (F) 9.3% (F) 0.2% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 25 50 75 100
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 BRAZIL POPULATION: 209 MILLION
WHO GLOBAL TB REPORT 2018

2017

91 000 FELL ILL WITH TB 7 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
6
62 000 29 000 11 000

Rate per 100 000 population per year

males females children
4

11 778
79 222 people not 2

TB cases notified or not

notified diagnosed including 1 900 deaths among
people with HIV 2017
0
2000 2005 2010 2015 2017

TREATMENT 80
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

60

Incidence
90 %
87% 72%
40

End TB Notified (new and relapse)

operational 20

targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

2 400
people fell ill with
drug-resistant TB
1 110 notified
11 000
people living with
2017 7 831 notified

964 notified and started on treatment HIV fell ill with TB 3 742 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 57 million
60
Not reported Not reported 50
HIV-positive people Children (aged <5 years) Unfunded
40
(newly enrolled
(US$ millions)

household contacts of 30 Funded

in care) on TB bacteriologically-confirmed TB internationally
20
preventive treatment cases on TB preventive treatment Funded
10
domestically
0

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
17.9% (M) 7.8% (M) 8.2% (M) 5 risk factors
28% 0.6% HIV
10.1% (F) 8.7% (F) 3.2% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 5 10 15
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 CAMBODIA POPULATION: 16 MILLION
WHO GLOBAL TB REPORT 2018

2017

52 000 FELL ILL WITH TB 3 500 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
60
30 000 22 000 6 600

Rate per 100 000 population per year

males females children 50

40

30
17 762
34 238 people not 20

TB cases notified or not

notified diagnosed
10

including 410 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 1000
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 800
TUBERCULOSIS

90 % 600
Incidence
66 % End TB
operational
94 % 400

targets
200
Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

1 200
people fell ill with
drug-resistant TB
136 notified

people living with

1 300 2017 748 notified

143 notified and started on treatment HIV fell ill with TB 698 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 37 million
40

21 %
44 % 35
30 Unfunded
HIV-positive people Children (aged <5 years) 25
(US$ millions)

20 Funded
(newly enrolled household contacts of internationally
15
in care) on TB bacteriologically-confirmed TB 10 Funded
preventive treatment cases on TB preventive treatment 5 domestically
0

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
33.7% (M) 7.4% (M) 7.6% (M) 5 risk factors
59% 0.6% HIV
2% (F) 6.9% (F) 1.4% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 5 10 15
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 CENTRAL
AFRICAN REPUBLIC
WHO GLOBAL TB REPORT 2018

POPULATION: 4.7 MILLION

2017

20 000 FELL ILL WITH TB 5 900 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
250
12 000 7 500 2 700

Rate per 100 000 population per year

males females children 200

150

10 336
9 664
100

people not
TB cases notified or not 50
notified diagnosed including 2 700 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 2000
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

1500

90 %
49 %
78 %
1000

End TB
operational 500
Incidence
targets Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

people fell ill with

drug-resistant TB
150
93 notified

people living with

6 200 2017 2 098 notified

86 notified and started on treatment HIV fell ill with TB 1 541 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 1.9 million
2

Not reported Not reported 1.5 Unfunded

HIV-positive people Children (aged <5 years)
(US$ millions)

1 Funded
(newly enrolled household contacts of internationally
in care) on TB bacteriologically-confirmed TB
preventive treatment
0.5 Funded
cases on TB preventive treatment domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking Data not available
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
8.0% (M) 5.5% (M) 5 risk factors
40% 4.0% — HIV
7.6% (F) 0.7% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 3 6 9 12
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 CHINA
POPULATION: 1 410 MILLION
WHO GLOBAL TB REPORT 2018

2017

889 000 FELL ILL WITH TB 39 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
12
600 000 289 000 99 000

Rate per 100 000 population per year

males females children 10

6
115 850
773 150 people not 4

TB cases notified or not

notified diagnosed
2

including 1 800 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 150
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 120
TUBERCULOSIS

90 % 90
Incidence
87 % End TB
operational
93 % 60

30
Notified (new and relapse)
targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

73 000
people fell ill with
drug-resistant TB
13 069 notified
12 000
people living with
2017 4 246 notified

—
5 943 notified and started on HIV fell ill with TB Not reported
treatment notified and on antiretroviral treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 609 million
800
Not reported Not reported 700
600 Unfunded
HIV-positive people Children (aged <5 years) 500
(US$ millions)

(newly enrolled household contacts of 400 Funded

in care) on TB bacteriologically-confirmed TB 300 internationally
preventive treatment cases on TB preventive treatment 200 Funded
100 domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
48.4% (M) 9.9% (M) 9.3% (M) 5 risk factors
32% — HIV
1.9% (F) 7.6% (F) 0.2% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 50 100 150 200
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 CONGO POPULATION: 5.3 MILLION
WHO GLOBAL TB REPORT 2018

2017

20 000 FELL ILL WITH TB 5 600 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
100
12 000 7 600 2 800

Rate per 100 000 population per year

males females children 80

60

9 995 40
10 005 people not
TB cases notified or not 20
notified diagnosed including 2 300 deaths among 0
people with HIV 2000 2005 2010 2015 2017

TREATMENT 800
TB INCIDENCE 2000-2017
2025 700

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

600

90 % 500
Incidence
51 %
77 %
400

End TB 300

operational 200
Notified (new and relapse)
targets 100

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

people fell ill with

drug-resistant TB
610
58 notified

people living with

5 300 2017 374 notified

28 notified and started on treatment HIV fell ill with TB 272 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 1.5 million

4.1%
2
Not reported
1.5 Unfunded
HIV-positive people Children (aged <5 years)
(US$ millions)

(newly enrolled household contacts of 1 Funded

in care) on TB internationally
bacteriologically-confirmed TB
preventive treatment cases on TB preventive treatment 0.5 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
52.3% (M) 7.7% (M) 3.1% (M) 5 risk factors
44% 3.1% HIV
1.7% (F) 7.6% (F) 0.4% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 2 4 6 8
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 DEMOCRATIC REPUBLIC
OF THE CONGO
WHO GLOBAL TB REPORT 2018

POPULATION: 81 MILLION
2017

262 000 FELL ILL WITH TB 56 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
120
162 000 99 000 33 000

Rate per 100 000 population per year

males females children 100

80

60
111 915
150 085 people not 40

TB cases notified or not

notified diagnosed
20

including 7 500 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 500
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 400
Incidence
TUBERCULOSIS

90 % 300

57 % End TB
operational
89% 200

100
Notified (new and relapse)
targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

7 500
people fell ill with
drug-resistant TB
893 notified
20 000
people living with
2017 9 688 notified

839 notified and started on treatment HIV fell ill with TB 7 982 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 74 million

15%
80
Not reported
60 Unfunded
HIV-positive people Children (aged <5 years)
(US$ millions)

(newly enrolled household contacts of 40 Funded

in care) on TB internationally
bacteriologically-confirmed TB
preventive treatment cases on TB preventive treatment 20 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
6.2% (M) 7.4% (M) 5 risk factors
37% 0.7% — HIV
6.1% (F) 0.9% (F)
Undernourishment Data not available

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 10 20 30 40
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 DEMOCRATIC PEOPLE’S
REPUBLIC OF KOREA
WHO GLOBAL TB REPORT 2018

POPULATION: 25 MILLION
2017

131 000 FELL ILL WITH TB 16 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
250
81 000 50 000 15 000

Rate per 100 000 population per year

males females children 200

150

30 447
100 553
100

people not
TB cases notified or not 50
notified diagnosed including 44 deaths among people
with HIV 0
2000 2005 2010 2015 2017

TREATMENT 600
TB INCIDENCE 2000-2017
Incidence
2025

Rate per 100 000 population per year

500
TB treatment coverage Treatment success rate
TUBERCULOSIS

90 %
400

77 % not reported
300

End TB 200 Notified (new and relapse)

operational
targets 100

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

5 200
people fell ill with
drug-resistant TB
1 515 notified

people living with

170 2017 Not reported
notified
—
—
1 732 notified and started on HIV fell ill with TB Not reported
treatment notified and on antiretroviral treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 84 million

100%
100
Not reported 80 Unfunded
HIV-positive people Children (aged <5 years)
(US$ millions)

60
(newly enrolled household contacts of Funded
in care) on TB 40 internationally
bacteriologically-confirmed TB
preventive treatment cases on TB preventive treatment 20 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
5.8% (M) 5.1% (M) 5 risk factors
— — — HIV
5.9% (F) 0.9% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 20 40 60
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 ETHIOPIA POPULATION: 105 MILLION
WHO GLOBAL TB REPORT 2018

2017

172 000 FELL ILL WITH TB 29 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
200
94 000 78 000 20 000

Rate per 100 000 population per year

males females children
150

100
55 275
116 725 people not
TB cases notified or not
50

notified diagnosed including 3 600 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 800
TB INCIDENCE 2000-2017
2025 700

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

600

90 % 500

68 %
90 %
400

End TB 300 Incidence

operational 200

targets 100 Notified (new and relapse)

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

5 500
people fell ill with
drug-resistant TB
680 notified
12 000
people living with
2017 7 272 notified

680 notified and started on treatment HIV fell ill with TB 6 673 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 93 million

11%
100

45 %
Children (aged <5 years)
80 Unfunded
HIV-positive people
(US$ millions)

60
household contacts of Funded
(newly enrolled 40 internationally
in care) on TB bacteriologically-confirmed TB
cases on TB preventive treatment Funded
preventive treatment 20
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
8.5% (M) 5.8% (M) 3.7% (M) 5 risk factors
38% 1.1% HIV
0.4% (F) 5.0% (F) 0.6% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 20 40 60
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 INDIA
POPULATION: 1 339 MILLION
WHO GLOBAL TB REPORT 2018

2017

2 740 000 FELL ILL WITH TB 421 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
80
1 780 000 954 000 224 000

Rate per 100 000 population per year

70
males females children
60

50

40
953 319
1 786 681 people not
30

TB cases notified or not

20

notified diagnosed 10
including 11 000 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 500
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 400
TUBERCULOSIS

90 % 300
Incidence

65% End TB
operational
69% 200

100
targets Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

135 000
people fell ill with
drug-resistant TB
39 009 notified
86 000
people living with
2017 36 440 notified

35 950 notified and started on HIV fell ill with TB 28 651 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 580 million

10% 11% 600

500 Unfunded
HIV-positive people Children (aged <5 years) 400
(US$ millions)

household contacts of Funded

(newly enrolled 300 internationally
in care) on TB bacteriologically-confirmed TB 200
cases on TB preventive treatment Funded
preventive treatment 100 domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
20.6% (M) 9.1% (M) 4.5% (M) 5 risk factors
65% 0.3% HIV
1.9% (F) 8.3% (F) 0.5% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 200 400 600
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 INDONESIA POPULATION: 264 MILLION
WHO GLOBAL TB REPORT 2018

2017

842 000 FELL ILL WITH TB 116 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
80
492 000 349 000 49 000

Rate per 100 000 population per year

70
males females children
60

50

40
399 828
442 172 people not
30

TB cases notified or not

20

notified diagnosed 10
including 9 400 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 500
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 400
Incidence
TUBERCULOSIS

90 % 300

53% End TB
operational
86% 200

targets
100
Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

23 000
people fell ill with
drug-resistant TB
5 070 notified
36 000
people living with
2017 7 729 notified

3 042 notified and started on HIV fell ill with TB 2 244 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 294 million

8.5%
300

16 %
Children (aged <5 years)
250
200
Unfunded
HIV-positive people
(US$ millions)

household contacts of 150 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB 100
cases on TB preventive treatment Funded
preventive treatment 50
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
76.1% (M) 7.4% (M) 1.3% (M) 5 risk factors
48% 0.4% HIV
2.8% (F) 8.0% (F) 0.3% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 100 200 300
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 KENYA POPULATION: 50 MILLION
WHO GLOBAL TB REPORT 2018

2017

158 000 FELL ILL WITH TB 43 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
150
106 000 53 000 21 000

Rate per 100 000 population per year

males females children 120

90

74 401
83 599
60
people not
TB cases notified or not 30
notified diagnosed including 18 000 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 1000
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 800
TUBERCULOSIS

90 % 600 Incidence

53% End TB
operational
81% 400

targets
200
Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

2 800
people fell ill with
drug-resistant TB
390 notified
45 000
people living with
2017 22 992 notified

394 notified and started on treatment HIV fell ill with TB 21 763 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 42 million

26%
50
Not reported 40 Unfunded
HIV-positive people Children (aged <5 years)
(US$ millions)

30
(newly enrolled household contacts of Funded
in care) on TB 20 internationally
bacteriologically-confirmed TB
preventive treatment cases on TB preventive treatment 10 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
20.4% (M) 5.8% (M) 5.8% (M) 5 risk factors
33% 5.4% HIV
1.2% (F) 6.2% (F) 0.8% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 10 20 30 40 50
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 LESOTHO POPULATION: 2.2 MILLION
WHO GLOBAL TB REPORT 2018

2017

15 000 FELL ILL WITH TB 5 600 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
150
9 200 5 700 2 200

Rate per 100 000 population per year

males females children 120

90

7 883
7 117
60
people not
TB cases notified or not 30
notified diagnosed including 4 600 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 2000
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

1500

90 % Incidence

48% 77%
1000

End TB
operational 500
Notified (new and relapse)
targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

1 100
people fell ill with
drug-resistant TB
351 notified
11 000
people living with
2017 4 690 notified

151 notified and started on treatment HIV fell ill with TB 4 310 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 3.3 million
3.5
Not reported Not reported 3
2.5 Unfunded
HIV-positive people Children (aged <5 years)
(US$ millions)

2 Funded
(newly enrolled household contacts of
in care) on TB bacteriologically-confirmed TB 1.5 internationally
1
preventive treatment cases on TB preventive treatment Funded
0.5 domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
53.9% (M) 7.3% (M) 7.5% (M) 5 risk factors
17% 25% HIV
0.4% (F) 9.9% (F) 1.1% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 2 4 6 8 10
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 LIBERIA POPULATION: 4.7 MILLION
WHO GLOBAL TB REPORT 2018

2017

15 000 FELL ILL WITH TB 3 600 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
120
9 000 5 500 1 900

Rate per 100 000 population per year

males females children 100

80

60
7 272
7 728 people not 40

TB cases notified or not

notified diagnosed
20

including 910 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 500
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 400
Incidence
TUBERCULOSIS

90 % 300

53 % End TB
operational
77% 200

targets
100
Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

people fell ill with

drug-resistant TB
390
88 notified

people living with

2 200 2017 827 notified

55 notified and started on treatment HIV fell ill with TB 347 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 6.4 million

5.8%
8
Not reported 7
6 Unfunded
HIV-positive people Children (aged <5 years) 5
(US$ millions)

(newly enrolled household contacts of 4 Funded

in care) on TB internationally
bacteriologically-confirmed TB 3
preventive treatment cases on TB preventive treatment 2 Funded
1 domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
18.1% (M) 7.8% (M) 7.4% (M) 5 risk factors
20% 1.6% HIV
1.5% (F) 7.6% (F) 1.1% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 2 4 6
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 MOZAMBIQUE POPULATION: 30 MILLION
WHO GLOBAL TB REPORT 2018

2017

163 000 FELL ILL WITH TB 48 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
150
101 000 62 000 23 000

Rate per 100 000 population per year

males females children 120

90

77 624
85 376
60

people not
TB cases notified or not 30
notified diagnosed including 27 000 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 800
TB INCIDENCE 2000-2017
2025 700

Rate per 100 000 population per year

TB treatment coverage Treatment success rate Incidence
TUBERCULOSIS

600

90 % 500

52 %
90 %
400

End TB 300

operational 200

targets 100 Notified (new and relapse)

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

8 800
people fell ill with
drug-resistant TB
861 notified
66 000
people living with
2017 33 514 notified

907 notified and started on treatment HIV fell ill with TB 31 790 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 30 million

100%
35
Not reported 30
25 Unfunded
HIV-positive people Children (aged <5 years)
(US$ millions)

20 Funded
(newly enrolled household contacts of
in care) on TB 15 internationally
bacteriologically-confirmed TB 10
preventive treatment cases on TB preventive treatment Funded
5 domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
29.1% (M) 6.6% (M) 4.8% (M) 5 risk factors
6.8% 12% HIV
5.1% (F) 6.2% (F) 0.6% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 15 30 45 60
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 MYANMAR POPULATION: 53 MILLION
WHO GLOBAL TB REPORT 2018

2017

191 000 FELL ILL WITH TB 32 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
250
123 000 68 000 23 000

Rate per 100 000 population per year

males females children 200

150

60 582
130 418
100

people not
TB cases notified or not 50
notified diagnosed including 4 900 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 600
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

500
TB treatment coverage Treatment success rate
TUBERCULOSIS

Incidence
90 %
400

68 %
88 %
300

End TB 200
Notified (new and relapse)
operational
targets 100

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

14 000
people fell ill with
drug-resistant TB
3 281 notified
17 000
people living with
2017 10 164 notified

2 666 notified and started on HIV fell ill with TB 6 371 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 58 million

2.1%
60

17 %
Children (aged <5 years)
50
40
Unfunded
HIV-positive people
(US$ millions)

household contacts of 30 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB 20
cases on TB preventive treatment Funded
preventive treatment 10
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
35.2% (M) 6.9% (M) 2.7% (M) 5 risk factors
74% 0.8% HIV
6.3% (F) 7.9% (F) 0.5% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 10 20 30 40 50
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 NAMIBIA POPULATION: 2.5 MILLION
WHO GLOBAL TB REPORT 2018

2017

11 000 FELL ILL WITH TB 1 500 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
80
6 300 4 400 1 800

Rate per 100 000 population per year

70
males females children
60

50

40
2 425
8 575 people not
30

TB cases notified or not

20

notified diagnosed 10
including 800 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 1200
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

1000
TB treatment coverage Treatment success rate
TUBERCULOSIS

90 %
800

Incidence
80 %
84 %
600

End TB 400
Notified (new and relapse)
operational
targets 200

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

people fell ill with

drug-resistant TB
950
409 notified

people living with

3 900 2017 3 139 notified

410 notified and started on treatment HIV fell ill with TB 3 021 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 49 million

34%
50

15 %
Children (aged <5 years)
40 Unfunded
HIV-positive people
(US$ millions)

30
household contacts of Funded
(newly enrolled 20 internationally
in care) on TB bacteriologically-confirmed TB
cases on TB preventive treatment Funded
preventive treatment 10
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
34.2% (M) 7.3% (M) 8.8% (M) 5 risk factors
8.3% 14% HIV
9.7% (F) 7.5% (F) 1.7% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 1 2 3 4 5
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 NIGERIA POPULATION: 191 MILLION
WHO GLOBAL TB REPORT 2018

2017

418 000 FELL ILL WITH TB 155 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
100
268 000 150 000 57 000

Rate per 100 000 population per year

males females children 80

60

315 613
102 387
40

people not
TB cases notified or not 20
notified diagnosed including 35 000 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 350
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

300

TB treatment coverage Treatment success rate

TUBERCULOSIS

250
Incidence
90 % 200

24 % End TB
operational
86% 150

100
Notified (new and relapse)
targets 50

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

24 000
people fell ill with
drug-resistant TB
2 286 notified
58 000
people living with
2017 13 516 notified

1 786 notified and started on HIV fell ill with TB 11 438 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 409 million

20%
500

39 %
Children (aged <5 years)
400 Unfunded
HIV-positive people
(US$ millions)

300
household contacts of Funded
(newly enrolled 200 internationally
in care) on TB bacteriologically-confirmed TB
cases on TB preventive treatment Funded
preventive treatment 100
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
10.8% (M) 6.3% (M) 3.8% (M) 5 risk factors
72% 2.9% HIV
0.6% (F) 6.0% (F) 0.4% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 25 50 75
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 PAKISTAN POPULATION: 197 MILLION
WHO GLOBAL TB REPORT 2018

2017

525 000 FELL ILL WITH TB 56 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
60
291 000 235 000 57 000

Rate per 100 000 population per year

males females children 48

36

165 776 24
359 224 people not
TB cases notified or not 12
notified diagnosed including 2 200 deaths among 0
people with HIV 2000 2005 2010 2015 2017

TREATMENT 400
TB INCIDENCE 2000-2017
2025 350

Rate per 100 000 population per year

TB treatment coverage Treatment success rate Incidence
TUBERCULOSIS

300

90 % 250

68 %
94 %
200

End TB 150

operational 100 Notified (new and relapse)

targets 50

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

27 000
people fell ill with
drug-resistant TB
3 475 notified

people living with

7 300 2017 121 notified

3 016 notified and started on HIV fell ill with TB 97 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 118 million
120
Not reported Not reported 100
Unfunded
HIV-positive people Children (aged <5 years) 80
(US$ millions)

(newly enrolled household contacts of 60 Funded

in care) on TB bacteriologically-confirmed TB internationally
40
preventive treatment cases on TB preventive treatment 20
Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
36.7% (M) 13% (M) 0.5% (M) 5 risk factors
66% 0.1% HIV
2.8% (F) 12% (F) 0.1% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 50 100 150
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 PAPUA
NEW GUINEA
WHO GLOBAL TB REPORT 2018

POPULATION: 8.3 MILLION

2017

36 000 FELL ILL WITH TB 5 300 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
200
23 000 13 000 3 900

Rate per 100 000 population per year

males females children
150

100
9 706
26 294 people not
TB cases notified or not
50

notified diagnosed including 930 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 800
TB INCIDENCE 2000-2017
2025 700

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

600

90 % Incidence
500

74% 62%
400

End TB 300

operational 200

targets 100 Notified (new and relapse)

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

1 900
people fell ill with
drug-resistant TB
356 notified

people living with

3 500 2017 791 notified

356 notified and started on treatment HIV fell ill with TB 753 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 28 million
30

16 % Not reported
Children (aged <5 years)
25
20
Unfunded
HIV-positive people
(US$ millions)

household contacts of 15 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB 10
preventive treatment cases on TB preventive treatment 5
Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
48.8% (M) 15% (M) 7.7% (M) 5 risk factors
5.8% 0.9% HIV
23.5% (F) 14% (F) 1.4% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 2.5 5.0 7.5 10
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 PHILIPPINES POPULATION: 105 MILLION
WHO GLOBAL TB REPORT 2018

2017

581 000 FELL ILL WITH TB 27 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
60
408 000 173 000 71 000

Rate per 100 000 population per year

males females children 48

36

263 734 24
317 266 people not
TB cases notified or not 12
notified diagnosed including 380 deaths among 0
people with HIV 2000 2005 2010 2015 2017

TREATMENT 1000
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 800
TUBERCULOSIS

Incidence
90 % 600

55% End TB
operational
91% 400

200
targets Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

27 000
people fell ill with
drug-resistant TB
6 438 notified

people living with

7 100 2017 1 335 notified

5 623 notified and started on HIV fell ill with TB 1 185 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 160 million

12%
200

57 %
Children (aged <5 years)
150 Unfunded
HIV-positive people
(US$ millions)

household contacts of 100 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB
cases on TB preventive treatment 50 Funded
preventive treatment domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
41% (M) 7.1% (M) 7.7% (M) 5 risk factors
54% 0.1% HIV
7.8% (F) 7.3% (F) 1.4% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 50 100 150
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 RUSSIAN
FEDERATION
WHO GLOBAL TB REPORT 2018

POPULATION   : 144 MILLION a

2017

86 000 FELL ILL WITH TB 12 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
25
60 000 26 000 2 600

Rate per 100 000 population per year

males females children 20

15

1 490 10
84 510 people not
TB cases notified or not 5
notified diagnosed including 1 700 deaths among 0
people with HIV 2000 2005 2010 2015 2017

TREATMENT 150
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 120
TUBERCULOSIS

90 % 90
Incidence
98 % End TB
operational
72 % 60

30
Notified (new and relapse)

targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

56 000
people fell ill with
drug-resistant TB
26 602 notified
18 000
people living with
2017 15 695 notified

26 457 notified and started on HIV fell ill with TB 9 748 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 1 435 million

100%
1500

97 %
Children (aged <5 years)
1200 Unfunded
HIV-positive people
(US$ millions)

900
household contacts of Funded
(newly enrolled 600 internationally
in care) on TB bacteriologically-confirmed TB
cases on TB preventive treatment Funded
preventive treatment 300
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
58.3% (M) 7.4% (M) 31% (M) 5 risk factors
36% — HIV
23.4% (F) 8.0% (F) 6.2% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 10 20 30
and inform the multisectoral actions required to end the TB epidemic. Thousands

a. UN Population Division estimates are lower than the population registered by the Federal State Statistics Service of the Russian Federation. ©World Health Organization 2018
 SIERRA LEONE POPULATION: 7.6 MILLION
WHO GLOBAL TB REPORT 2018

2017

23 000 FELL ILL WITH TB 3 700 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
150
13 000 9 300 2 500

Rate per 100 000 population per year

males females children 120

90

7 065
15 935
60
people not
TB cases notified or not 30
notified diagnosed including 780 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 500
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 400
TUBERCULOSIS

Incidence
90 % 300

70 % End TB
operational
89% 200

targets
100
Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

people fell ill with

drug-resistant TB
660
174 notified

people living with

2 800 2017 1 970 notified

104 notified and started on treatment HIV fell ill with TB 1 911 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 16 million
20

22 % Not reported
Children (aged <5 years)
15 Unfunded
HIV-positive people
(US$ millions)

household contacts of 10 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB
preventive treatment cases on TB preventive treatment 5 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
41.3% (M) 7.1% (M) 4.9% (M) 5 risk factors
38% 1.7% HIV
8.8% (F) 6.6% (F) 0.5% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 2.5 5.0 7.5
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 SOUTH AFRICA POPULATION: 57 MILLION
WHO GLOBAL TB REPORT 2018

2017

322 000 FELL ILL WITH TB 78 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
80
187 000 135 000 38 000

Rate per 100 000 population per year

70
males females children
60

50

40
101 837
220 163 people not
30

TB cases notified or not

20

notified diagnosed 10
including 56 000 deaths among 0
people with HIV 2000 2005 2010 2015 2017

TREATMENT 1500
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 1200
TUBERCULOSIS

Incidence
90 % 900

68 % End TB
operational
82% 600

300
Notified (new and relapse)
targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

14 000
people fell ill with
drug-resistant TB
193 000
people living with
2017 123 148 notified

10 259 notified and on treatment HIV fell ill with TB 109 799 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 271 million

79%
300

53 %
Children (aged <5 years)
250
200
Unfunded
HIV-positive people
(US$ millions)

household contacts of 150 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB 100
cases on TB preventive treatment Funded
preventive treatment 50
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
33.2% (M) 9.7% (M) 10% (M) 5 risk factors
7.7% 19% HIV
8.1% (F) 13% (F) 1.5% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 50 100 150 200
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 THAILAND POPULATION: 69 MILLION
WHO GLOBAL TB REPORT 2018

2017

108 000 FELL ILL WITH TB 12 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
35
71 000 37 000 8 500

Rate per 100 000 population per year

30
males females children
25

20

27 840 15
80 160 people not 10
TB cases notified or not
notified diagnosed
5
including 2 900 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 400
TB INCIDENCE 2000-2017
2025 350

Rate per 100 000 population per year

TB treatment coverage Treatment success rate
TUBERCULOSIS

300

90 % 250

Incidence
74 %
83 %
200

End TB 150

operational 100

targets 50 Notified (new and relapse)

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

3 900
people fell ill with
drug-resistant TB
1 339 notified
11 000
people living with
2017 7 130 notified

851 notified and started on treatment HIV fell ill with TB 4 577 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 26 million

5%
30
Not reported 25
Unfunded
HIV-positive people Children (aged <5 years) 20
(US$ millions)

(newly enrolled household contacts of 15 Funded

in care) on TB internationally
bacteriologically-confirmed TB 10
preventive treatment cases on TB preventive treatment 5
Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
38.8% (M) 8.3% (M) 9.1% (M) 5 risk factors
12% 1.1% HIV
1.9% (F) 8.8% (F) 1.0% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 5 10 15 20 25
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 UNITED REPUBLIC
OF TANZANIA
WHO GLOBAL TB REPORT 2018

POPULATION: 57 MILLION
2017

154 000 FELL ILL WITH TB 49 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
150
104 000 50 000 8 700

Rate per 100 000 population per year

males females children 120

90

85 527
68 473
60
people not
TB cases notified or not 30
notified diagnosed including 22 000 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 1000
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 800
TUBERCULOSIS

90 % 600

44% End TB
operational
90% 400

200
Incidence
Notified (new and relapse)
targets
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

1 700
people fell ill with
drug-resistant TB
200 notified
48 000
people living with
2017 21 449 notified

167 notified and started on treatment HIV fell ill with TB 20 314 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 64 million

35%
80
Not reported
60 Unfunded
HIV-positive people Children (aged <5 years)
(US$ millions)

(newly enrolled household contacts of 40 Funded

in care) on TB internationally
bacteriologically-confirmed TB
preventive treatment cases on TB preventive treatment 20 Funded
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
26.7% (M) 6.0% (M) 9.3% (M) 5 risk factors
26% 4.7% HIV
3.3% (F) 6.1% (F) 1.8% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 20 40 60 80
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 VIET NAM POPULATION: 96 MILLION
WHO GLOBAL TB REPORT 2018

2017

124 000 FELL ILL WITH TB 12 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
60
87 000 37 000 15 000

Rate per 100 000 population per year

males females children 50

40

30
21 275
102 725 people not 20
TB cases notified or not
notified diagnosed
10

including 840 deaths among

people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 300
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

250
TB treatment coverage Treatment success rate
TUBERCULOSIS

90 %
200
Incidence

83% 92%
150

End TB
operational
100
Notified (new and relapse)
targets 50

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

7 100
people fell ill with
drug-resistant TB
3 071 notified

people living with

4 500 2017 3 239 notified

2 694 notified and started on HIV fell ill with TB 3 054 notified and on antiretroviral
treatment treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 70 million

26%
80

31 %
Children (aged <5 years)
60 Unfunded
HIV-positive people
(US$ millions)

household contacts of 40 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB
cases on TB preventive treatment 20 Funded
preventive treatment domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
45.9% (M) 5.5% (M) 8.7% (M) 5 risk factors
43% 0.4% HIV
1.0% (F) 5.1% (F) 0.9% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 10 20 30
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 ZAMBIA POPULATION: 17 MILLION
WHO GLOBAL TB REPORT 2018

2017

62 000 FELL ILL WITH TB 18 000 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
80
38 000 24 000 7 500

Rate per 100 000 population per year

70
males females children
60

50

40
25 990
36 010 people not
30

TB cases notified or not

20

notified diagnosed 10
including 13 000 deaths among 0
people with HIV 2000 2005 2010 2015 2017

TREATMENT 1200
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

1000
TB treatment coverage Treatment success rate
TUBERCULOSIS

90 %
800

58 %
88 %
600
Incidence
End TB 400
operational Notified (new and relapse)
targets 200

0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

1 900
people fell ill with
drug-resistant TB
546 notified
36 000
people living with
2017 20 362 notified

270 notified and started on treatment HIV fell ill with TB 18 341 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 38 million

3.8%
40

18 %
Children (aged <5 years)
30 Unfunded
HIV-positive people
(US$ millions)

household contacts of 20 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB
cases on TB preventive treatment 10 Funded
preventive treatment domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
24.7% (M) 6.5% (M) 7.9% (M) 5 risk factors
28% 12% HIV
3.1% (F) 6.7% (F) 1.0% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 10 20 30 40
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018
 ZIMBABWE POPULATION: 17 MILLION
WHO GLOBAL TB REPORT 2018

2017

37 000 FELL ILL WITH TB 8 300 TB DEATHS TB MORTALITY 2000-2017

(Excludes people with HIV)
50
21 000 15 000 5 600

Rate per 100 000 population per year

males females children 40

30

11 152
25 848
20
people not
TB cases notified or not 10
notified diagnosed including  6300 deaths among
people with HIV 0
2000 2005 2010 2015 2017

TREATMENT 1000
TB INCIDENCE 2000-2017
2025

Rate per 100 000 population per year

TB treatment coverage Treatment success rate 800
TUBERCULOSIS

90 % 600

71% End TB
operational
81% 400
Incidence

targets
200
Notified (new and relapse)
0
2000 2005 2010 2015 2017
GLOBAL

REPORT

DRUG-RESISTANT TB TB/HIV

2 300
people fell ill with
drug-resistant TB
474 notified
23 000
people living with
2017 16 602 notified

439 notified and started on treatment HIV fell ill with TB 14 300 notified and on antiretroviral
treatment

TB PREVENTIVE TREATMENT TB FINANCING 2018

National TB budget USD 30 million

24%
30

11 %
Children (aged <5 years)
25
20
Unfunded
HIV-positive people
(US$ millions)

household contacts of 15 Funded

(newly enrolled internationally
in care) on TB bacteriologically-confirmed TB 10
cases on TB preventive treatment Funded
preventive treatment 5
domestically
0
2018

TB-SDG MONITORING FRAMEWORK

Alcohol use disorders, Alcohol

Out-of-pocket health HIV prevalence Smoking prevalence Diabetes prevalence 12 month prevalence Number of
expenditure (% of current (% of population (% of population (% of population (% of population TB cases Smoking
health expenditure) aged 15—49 years) aged ≥15 years) aged ≥18 years) aged ≥15 years) attributable to Diabetes
30.7% (M) 6.5% (M) 9.0% (M) 5 risk factors
26% 14% HIV
1.6% (F) 7.6% (F) 1.6% (F)
Undernourishment

Monitoring of the above indicators can be used to identify key influences on the TB epidemic at national level 0 5 10 15 20 25
and inform the multisectoral actions required to end the TB epidemic. Thousands
©World Health Organization 2018